Beyond Air Inc (NASDAQ: XAIR) kicked off on Tuesday, up 150.00% from the previous trading day, before settling in for the closing price of $0.88. Over the past 52 weeks, XAIR has traded in a range of $0.67-$10.40.
During the last 5-year period, the sales growth of Healthcare Sector giant was 17.29%. While this was happening, its average annual earnings per share was recorded 73.14%. With a float of $7.54 million, this company’s outstanding shares have now reached $8.01 million.
Beyond Air Inc (XAIR) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Beyond Air Inc is 5.87%, while institutional ownership is 18.88%. The most recent insider transaction that took place on Jul 21 ’25, was worth 19,491. In this transaction CEO and Chairman of the Board of this company bought 6,000 shares at a rate of $3.25, taking the stock ownership to the 3,327,411 shares. Before that another transaction happened on Mar 14 ’25, when Company’s Director bought 1,000,000 for $0.25, making the entire transaction worth $250,050. This insider now owns 4,076,864 shares in total.
Beyond Air Inc (XAIR) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -3 earnings per share (EPS), higher than consensus estimate (set at -3.2) by 0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 74.09% during the next five years compared to 17.29% growth over the previous five years of trading.
Beyond Air Inc (NASDAQ: XAIR) Trading Performance Indicators
Take a look at Beyond Air Inc’s (XAIR) current performance indicators. Last quarter, stock had a quick ratio of 3.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.53, a number that is poised to hit -0.68 in the next quarter and is forecasted to reach -2.07 in one year’s time.
